Company Overview - Foresight Medical Technology (01696.HK) is the first Israeli company listed on the Hong Kong Stock Exchange, established in 2013. Its core subsidiary, Alma, is a leading provider of energy-based surgical and aesthetic medical devices globally [2][3]. - The company is a key platform for Fosun Pharma in the medical aesthetics sector, focusing on creating a consumer-centric ecosystem for beauty and health with a diverse product portfolio and a strong global presence in over 100 countries [2][3]. Financial Performance - As of December 31, 2024, Foresight Medical Technology reported total revenue of 2.51 billion yuan, a year-on-year decrease of 2.83%. The net profit attributable to shareholders was 181 million yuan, down 20.23% year-on-year. The gross profit margin stood at 62.07%, and the debt-to-asset ratio was 22.71% [1]. Market Position and Valuation - The company has a price-to-earnings (P/E) ratio of 15.42, ranking 24th in the healthcare equipment and services industry, where the average P/E ratio is 0.69 and the median is 1.36 [2]. - Other companies in the industry have significantly lower P/E ratios, such as Jingjiu Health (00648.HK) at 0.38 and Giant Medical Holdings (02393.HK) at 0.41, indicating a relatively higher valuation for Foresight Medical Technology [2]. Strategic Goals - The company's objectives extend beyond developing medical-grade beauty and health solutions; it aims to enhance the overall quality of consumers' daily lives and create real value in the health sector. Its multi-layered strategy facilitates cross-marketing of products, providing various cross-brand solutions to business partners, professional clients, and consumers [3]. Upcoming Events - The company is scheduled to disclose its mid-year report for the fiscal year 2025 on August 20, 2025. Additionally, it plans to distribute a final dividend of HKD 0.126 per share for the fiscal year 2024, with the ex-dividend date on August 26, 2025, and the payment date on September 9, 2025 [4].
复锐医疗科技（01696.HK）8月15日收盘上涨10.9%，成交2313.05万港元